前列腺癌中纯能信号和氧化应激之间的关系:未来治疗前景
Rafael Zatti Rossetto1, Sarah Franco Vieira De Oliveira Maciel1, Andréia Machado Cardoso1
1Graduate Program of Biomedical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil.
Critical reviews in oncology/hematology
|February 27, 2025
概括
纯能信号和反应性物种影响前列腺癌 (PCa) 的进展. 针对这些途径为PCa治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 前列腺癌 (PCa) 是男性癌症相关死亡的重要原因之一.
- PCa的危险因素包括年龄,遗传和生活方式.
- 瘤微环境 (TME) 在PCa进展中起着至关重要的作用.
研究的目的:
- 审查纯能信号和反应性物种在PCa进展中的作用.
- 阐明这些因素在TME中的相互作用.
- 为了确定PCa的潜在治疗点.
主要方法:
- 对纯能信号通路 (ATP,腺,P1/P2受体,CD39,CD73) 的文献综述.
- 分析反应性氧物种 (ROS) 和反应性物种 (RNS) 在PCa中的作用.
- 检查TME中的纯能信号和反应性物种之间的相互作用.
主要成果:
- 纯能系统的变化 (例如,P2X7,P2X4受体) 影响PCa细胞增殖,血管生成和免疫逃避.
- 较高的ROS/RNS水平会导致氧化损伤,促进遗传不稳定性和不受控制的细胞生长.
- 像CD39和CD73这样的酶在将ATP降解为腺和防止氧化损伤方面具有双重作用.
- 在TME中,由ATP和ROS调解的炎症和免疫抑制信号之间的平衡决定了瘤的命运.
结论:
- 纯能信号和反应性物种是PCa TME的关键调节者.
- 这些途径之间的复杂相互作用为治疗提供了新的机会.
- 准纯能受体和ROS调节对未来的PCa治疗有希望.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:31Internal Receptors
69.2K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.2K
01:24Peroxisomes
9.2K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
9.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K